• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET avoids need for liver resection in colon cancer patients

Article

A multicenter prospective trial in the Netherlands has found that FDG-PET prevents unnecessary surgeries for one in six patients with metastatic colon cancer who undergo liver resection based on CT findings.

A multicenter prospective trial in the Netherlands has found that FDG-PET prevents unnecessary surgeries for one in six patients with metastatic colon cancer who undergo liver resection based on CT findings.

Dr. W.J.G. Oyen of Radboud University Nijmegen Medical Center and colleagues enrolled 75 surgical candidates randomly selected for assessment with CT alone, the standard imaging for recommending surgery, and another 75 who were evaluated with CT and FDG-PET. All 75 patients in the CT group underwent laparotomy compared to 70 in the PET group. Overall, surgeries for 34 (45%) and 21 (28%) patients performed on the basis of CT or CT plus PET, respectively, were considered futile. Disease recurred within six months in almost a third of patients in the CT-only group. Oyen presented results at the 2008 SNM meeting in New Orleans, Louisiana.

-By H.A. Abella

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.